Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Apr 29, 2024

BUY
$233.08 - $265.59 $451,709 - $514,713
1,938 New
1,938 $480,000
Q1 2023

Sep 15, 2023

SELL
$239.75 - $277.0 $70,966 - $81,992
-296 Reduced 13.25%
1,938 $488,000
Q1 2023

May 08, 2023

SELL
$239.75 - $277.0 $70,966 - $81,992
-296 Reduced 13.25%
1,938 $488,000
Q4 2022

Sep 15, 2023

BUY
$241.42 - $282.29 $71,460 - $83,557
296 Added 15.27%
2,234 $593,000
Q4 2022

Feb 13, 2023

BUY
$241.42 - $282.29 $539,332 - $630,635
2,234 New
2,234 $0

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Oversea Chinese Banking Corp LTD Portfolio

Follow Oversea Chinese Banking Corp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oversea Chinese Banking Corp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oversea Chinese Banking Corp LTD with notifications on news.